Effect of Perioperative Oral Ascorbic Acid in Combination with Beta Blockers in Comparison to Beta Blockers Alone on Atrial Fibrillation in Elective Off Pump Coronary Artery Bypass Grafting
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Siddhi Banerjee und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Atrial fibrillation is a common postoperative complication after CABG, mainly linked to oxidative stress and inflammation, occurring in 30–50% of patients. Risk factors include age, diabetes, hypertension, and heart disease. Vitamin C, an antioxidant, may reduce POAF by limiting oxidative injury and improving endothelial function. Despite beta-blocker use, additional prevention is needed, warranting further studies on vitamin C therapy.
Aims
The aim of this study is to determine the effect of oral ascorbic acid in combination with beta-blockers on the incidence of postoperative atrial fibrillation in patients undergoing elective off-pump CABG. The objectives are to assess and compare the effectiveness of perioperative oral ascorbic acid with beta-blockers versus betablockers alone in preventing atrial fibrillation in these patients, and to evaluate any adverse events occurring in both treatment groups. Materials and Methods: This randomized controlled single-blinded study was conducted in the Department of Cardiac Anaesthesia, NRSMCH, Kolkata, over 18 months (August 2024–February 2025). The study included 100 patients undergoing elective CABG. Participants were allocated to receive oral ascorbic acid with beta-blockers or beta-blockers alone, and outcomes were compared for POAF incidence.
Result
The study groups were comparable in baseline, comorbidities, perioperative variables, echocardiographic parameters, and medication use. Postoperative atrial fibrillation was significantly lower in Vitamin C group (6% vs 28%, p=0.003). Other outcomes including transfusion, ventilation, ICU stay showed no significant difference.
Conclusion
The study concluded that oral ascorbic acid with beta-blockers is more effective than beta-blockers alone in preventing postoperative atrial fibrillation after off-pump CABG. Older age, diabetes mellitus, and postoperative blood transfusion were identified as independent risk factors for developing atrial fibrillation.
Zitieren
APA
Banerjee, S., Majumder, S., Dasghara, A., & Gupta, S. D. (2026). Effect of Perioperative Oral Ascorbic Acid in Combination with Beta Blockers in Comparison to Beta Blockers Alone on Atrial Fibrillation in Elective Off Pump Coronary Artery Bypass Grafting. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.122
Vancouver
Banerjee S, Majumder S, Dasghara A, Gupta SD. Effect of Perioperative Oral Ascorbic Acid in Combination with Beta Blockers in Comparison to Beta Blockers Alone on Atrial Fibrillation in Elective Off Pump Coronary Artery Bypass Grafting. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.122
BibTeX
@article{Banerjee2026,
author = {Banerjee, Siddhi and Majumder, Saptaki and Dasghara, Aditi and Gupta, Sampa Dutta},
title = {Effect of Perioperative Oral Ascorbic Acid in Combination with Beta Blockers in Comparison to Beta Blockers Alone on Atrial Fibrillation in Elective Off Pump Coronary Artery Bypass Grafting},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.122}
}
EUVIMED